Search Results

Ajay Yekkirala shares the journey from academic pharmacologist to biotech entrepreneur—bridging curiosity When the global biotech crowd lands in Boston for Discovery on Target. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Tools The Story Behind Celtarys – From Chemistry to Company   How does a medicinal chemist become a biotech Explore this week’s research, tools, and biotech insights in one place.

GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr. GPCR Foundry: Science Meets Execution The Foundry is where we bring together biotech innovators, Venture , he shares decades of expertise in an accessible, on-demand format for scientists across academia, biotech

Kenakin Trusted insights across biotech, pharma, and academia 💎 $2,999/year — one conference cost = embracing serendipity, Eric shares the mindset (and messy origin stories) that shaped tools now used across biotech GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Dive into this week’s research, tools, and biotech updates all in one place.

Watch Episode 168 What does it take for a scientist to become a startup leader in biotech? For Dr.

Highlights: • The Foundry Arrives : R&D meets biotech with real-world acceleration, strategic consulting GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

work at Alkermes didn’t just improve drug screening outcomes, it redefined what great leadership in biotech

GPCR Premium Membership Gives You an Edge Premium gives GPCR scientists and biotech teams a single, trusted Researchers, pharmacologists, biotech teams, and decision-makers who rely on accurate, efficient, interpretation-first

Biotech teams, CRO alliances, and academic consortia face the same challenge: how to align incentives This ecosystem design blueprint applies to biotech teams and academic consortia alike.

Explore this week’s research, tools, and biotech insights in one place.

Kenakin Trusted insights from biotech, pharma, and academia 🎬 Plus New: Lesson Trailers   Curious about GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

In this podcast, he lays out the mindset that helped shape products used across biotech and academia—and teaming, testing, and failing smarter. 🚀 Why This Matters: Whether you’re launching a tool, starting a biotech

His hybrid path is a model of possibility for professionals in the biotech industry who still dream of

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need tools, translational strategy, classified updates, and curated jobs—trusted by scientists, teams, and biotech

🔹 Spot the opportunity → Why Catalio is betting big when others pull back Amid biotech slowdowns

Explore this week’s research, tools, and biotech insights in one place.

. 👉 In biotech, where cycles are long and feedback is slow, this gap becomes even more pronounced. Biotech teams operate across disciplines, timelines, and incentives. Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, not

Did you know that each month we collect the most recent #GPCR publications and the newest Biotech/Pharma

School of Medicine to Receive $3-Million Award from ARPA-H’s Sprint for Women’s Health Nxera Pharma Wins Biotech Year and Financing Deal of the Year at the Citeline Japan Awards 2024 GPCR therapies: Eight promising biotechs

(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company

productive lab—it accelerated outcomes and laid the cultural foundation for the next generation of biotech insights from major conferences, emerging research, and expert commentary Whether you’re a pharmacologist, biotech

Industry News Domain Therapeutics was one of the 4 Biotech Trophy nominees at 2023 HealthTech awards. The delisting dilemma: Why do so many biotechs face being kicked off the Nasdaq?. (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition

Explore this week’s research, tools, and biotech insights in one place.

Explore this week’s research, tools, and biotech insights in one place. The insights are ready.

insights from major conferences, emerging research, and expert commentary Whether you’re a pharmacologist, biotech GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

The Boston biotech revealed Wednesday afternoon that it would downsize its research to focus on its lead

About Celtarys Research Celtarys Research is a biotech company based in Spain that specializes in the

pathway of opioid drugs into cellular structures Inversago Pharma will present at BBHIC 2023 Orion Biotechnology attended the Swiss Biotech Day Addex Therapeutics attended the Swiss Biotech Day Sosei Heptares presented

January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers